Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients

British Journal of Cancer

Volumn 83, Issue 12, 2000, Pages 1664-1673

  Austrup, F ^a   Uciechowski, P ^a   Eder, C ^a   Bockmann B ^a   Suchy, B ^a   Driesel, G ^a   Jackel S ^a   Kusiak, I ^a   Grill, H J ^a   Giesing, M ^a  

^a Inst fur Molekulare NanoTechnologie   (Germany)

Author keywords

Blood; Breast cancer prognosis; Genomic imbalances; Minimal residual cancer cells

Indexed keywords

DNA; ONCOPROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISSEMINATED CANCER; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL ADHESION MOLECULES; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM CIRCULATING CELLS; NEOPLASM, RESIDUAL; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2; RECEPTORS, CELL SURFACE; RETINOBLASTOMA PROTEIN; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0034538226     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1501     Document Type: Article

References (35)

1. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells
2. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis
3. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization
4. Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients
5. Loss of heterozygosity at 11q22-q23 in breast cancer
6. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology
7. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction
8. Hot spots mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites
9. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction
10. Allelic loss on chromosomes 8p, 22q and 18q (DCC) in human prostate cancer
11. Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: Studies on the epithelial glycoprotein gene EGP-2
12. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients
13. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics
14. Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro
15. The 1993-94 Genethon human genetic linkage map
16. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome
17. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations
18. Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction
19. Dinucleotide repeat polymorphism at the D11S528 locus
20. The status of p53 in the metastatic progression of colorectal cancer
21. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers
22. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer
23. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor
24. Role of the p16 tumor suppressor gene in cancer
25. Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer
26. Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR)
27. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene
28. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
29. Microsatellite alterations in serum DNA of head and neck cancer patients
30. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons
31. P53 gene mutations are not required for early dissemination of cancer cells
32. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients
33. CA repeat polymorphism at the D5S299 locus linked to adenomatous polyposis coli (APC)
34. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression
35. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow